"From Q2 onwards, we expected to get back to double digit growth and are very happy that it is happening in Q1 itself. The growth year on y...

Of the 44 analysts, 18 of them have a 'sell' rating while 15 remain neutral. On aggregate, analysts slashed consensus price targets by 4.35...

"At least 30-40 generic brands are expected to hit the market next in a couple of weeks," said Hari Natarajan, managing director, Pronto Co...

"Following the price reduction, Cidmus will be priced at Rs 29 for 50 mg (down from Rs 78.32); Rs 49 for 100 mg (down from Rs 83.86); Rs 79...

Athenex, which is into the development of cell therapies to treat cancers, had hired investment advisory firm Cowen Inc to run a formal pro...

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 72169.74 Crore) operating i...

The US market with its headwinds related to increased competitive intensity, pricing pressures and high regulations, has not remained as lu...

Auto manufacturers, which have announced their sales numbers for the month of March, will remain under focus.

Dr. Reddy’s will look to leverage its wide base to engage with healthcare professionals, and to significantly enhance the reach of the prod...

According to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December...